These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 11387906)
21. The dilemma of antimicrobial treatment of Shiga toxin-producing Escherichia coli. Mor M; Ashkenazi S Pediatr Infect Dis J; 2014 Sep; 33(9):979-81. PubMed ID: 25361025 [No Abstract] [Full Text] [Related]
23. Elevated tissue factor levels in children with hemolytic uremic syndrome. Bhowmik D Clin Nephrol; 2001 Mar; 55(3):262. PubMed ID: 11316251 [No Abstract] [Full Text] [Related]
24. [Shiga toxin production by Escherichia coli strains and antibiotics]. Sidorenko SV Antibiot Khimioter; 2001; 46(5):3-5. PubMed ID: 11558452 [No Abstract] [Full Text] [Related]
25. Strategy to prevent the progression of enterohemorrhagic Escherichia coli O157 infection to hemolytic uremic syndrome. Takeda T Jpn J Med Sci Biol; 1998; 51 Suppl():S124-8. PubMed ID: 10211445 [No Abstract] [Full Text] [Related]
26. Escherichia coli O157 fails to induce a long-lasting lipopolysaccharide-specific, measurable humoral immune response in children with hemolytic-uremic syndrome. Ludwig K; Bitzan M; Bobrowski C; Müller-Wiefel DE J Infect Dis; 2002 Aug; 186(4):566-9. PubMed ID: 12195387 [TBL] [Abstract][Full Text] [Related]
29. Hemolytic uremic syndrome: an emerging health risk. Razzaq S Am Fam Physician; 2006 Sep; 74(6):991-6. PubMed ID: 17002034 [TBL] [Abstract][Full Text] [Related]
30. Hemolytic uremic syndrome surveillance to monitor trends in infection with Escherichia coli O157:H7 and other shiga toxin-producing E. coli. Mahon BE; Griffin PM; Mead PS; Tauxe RV Emerg Infect Dis; 1997; 3(3):409-12. PubMed ID: 9284395 [No Abstract] [Full Text] [Related]
31. Leukocytosis as a predictor for progression to haemolytic uraemic syndrome in Escherichia coli O157:H7 infection. Anjay MA; Anoop P; Britland A Arch Dis Child; 2007 Sep; 92(9):820-3. PubMed ID: 17715449 [No Abstract] [Full Text] [Related]
32. [Enterohemorrhagic Escherichia coli and hemolytic-uremic syndrome in Argentina]. Rivero MA; Padola NL; EtcheverrÃa AI; Parma AE Medicina (B Aires); 2004; 64(4):352-6. PubMed ID: 15338982 [TBL] [Abstract][Full Text] [Related]
33. Does levofloxacin induce hemolytic uremic syndrome in patients infected with verotoxin-producing Escherichia coli O157 infections? Ohnishi K; Nakamura-Uchiyama F Jpn J Infect Dis; 2012; 65(5):442-3. PubMed ID: 22996222 [TBL] [Abstract][Full Text] [Related]
34. Escherichia coli O157:H7 as the predominant pathogen associated with the hemolytic uremic syndrome: a prospective study in the Pacific Northwest. Neill MA; Tarr PI; Clausen CR; Christie DL; Hickman RO Pediatrics; 1987 Jul; 80(1):37-40. PubMed ID: 3299236 [TBL] [Abstract][Full Text] [Related]
35. [Intestinal infections with Escherichia coli type O157]. Bol P Ned Tijdschr Tandheelkd; 2000 Feb; 107(2):73-4. PubMed ID: 11385801 [No Abstract] [Full Text] [Related]
36. An outbreak of hemolytic uremic syndrome due to Escherichia coli O157:H7: or was it? Goldwater PN; Bettelheim KA Emerg Infect Dis; 1996; 2(2):153-4. PubMed ID: 8903222 [No Abstract] [Full Text] [Related]
37. Escherichia coli O157:H7 infections: a frequent cause of bloody diarrhea and the hemolytic-uremic syndrome. Cohen MB Adv Pediatr; 1996; 43():171-207. PubMed ID: 8794177 [No Abstract] [Full Text] [Related]
38. Hemolytic uremic syndrome caused by E. coli O157 infection. Bystrom PV; Beck RJ; Prahlow JA Forensic Sci Med Pathol; 2017 Jun; 13(2):240-244. PubMed ID: 28352987 [No Abstract] [Full Text] [Related]
39. [Guidelines for the diagnosis and treatment of hemolytic uremic syndrome (HUS) with enterohemorrhagic colitis]. Okada M Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():269-72. PubMed ID: 17455629 [No Abstract] [Full Text] [Related]
40. [Hemolytic uremic syndrome as of 2013]. Loirat C; Mariani-Kurkdjian P; Fremeaux-Bacchi V Arch Pediatr; 2013 Aug; 20(8):827-30. PubMed ID: 23835098 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]